Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.53 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.52 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.48 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.47 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30521932 | 1.00 | CYP1A1 (0.54) | CYP1A1CYP1B1CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL28136196 | 0.95 | CYP1A1 (0.53) | CYP1A1CYP1B1CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL25954683 | 0.92 | MAPKAPK2 (0.53) | CYP1A1CYP1B1CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL25633168 | 0.91 | SIRT2 (0.50) | CYP1A1CYP1B1CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL18334883 | 0.88 | NPC1 (0.50) | CYP1A1CYP1B1CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL15977625 | 0.87 | CYP1A1 (0.43) | CYP1A1CYP1B1CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL24291931 | 0.86 | ASIC3 (0.61) | ASIC3MAPKAPK2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29854571 | 0.86 | ASIC3 (0.61) | ASIC3MAPKAPK2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL17694751 | 0.86 | ASIC3 (0.61) | ASIC3MAPKAPK2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL21692157 | 0.86 | ASIC3 (0.65) | ASIC3MAPKAPK2ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9212197-B2 | Phosphorescent heteroleptic phenylbenzimidazole dopants | UNIVERSAL DISPLAY CORPORATION (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212197-B2 | Phosphorescent heteroleptic phenylbenzimidazole dopants | UNIVERSAL DISPLAY CORPORATION (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212197-B2 | Phosphorescent heteroleptic phenylbenzimidazole dopants | UNIVERSAL DISPLAY CORPORATION (US) | 2015-12-15 | — | — | US | disclosed |
| US-20120292600-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120292600-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120292600-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120292600-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS | OCIAD1, OCIAD2, ODC1 | CYP1A1 3610/4885CYP1B1 3505/4885CYP17A1 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.